Deutsche Bank Ag\ Intellia Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 225,219 shares of NTLA stock, worth $2.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

225,219

Previous 212,457 6.01%

Holding current value

$2.95 Million

Previous $4.75 Million 2.65%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$19.72 - $27.36 $251,666 - $349,168	12,762 Added 6.01%	225,219 $4.63 Million
Q2 2024 Aug 14, 2024	SELL	$20.02 - $27.22 $32,412 - $44,069	-1,619 Reduced 0.76%	212,457 $4.75 Million
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $350,558 - $482,717	-14,717 Reduced 6.43%	214,076 $5.89 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $2.03 Million - $2.83 Million	87,619 Added 62.06%	228,793 $6.98 Million
Q3 2023 Nov 09, 2023	SELL	$31.62 - $45.78 $2.13 Million - $3.08 Million	-67,242 Reduced 32.26%	141,174 $4.46 Million
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $1.6 Million - $2.13 Million	46,180 Added 28.46%	208,416 $8.5 Million
Q1 2023 May 15, 2023	BUY	$33.3 - $44.82 $217,315 - $292,495	6,526 Added 4.19%	162,236 $6.05 Million
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $300,351 - $566,968	9,044 Added 6.17%	155,710 $5.43 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $2.4 Million - $3.19 Million	44,540 Added 43.61%	146,666 $8.21 Million
Q2 2022 Aug 11, 2022	SELL	$38.49 - $76.21 $1.6 Million - $3.17 Million	-41,637 Reduced 28.96%	102,126 $5.29 Million
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $2.33 Million - $4.76 Million	-40,031 Reduced 21.78%	143,763 $10.4 Million
Q4 2021 Feb 11, 2022	BUY	$100.76 - $138.36 $83,731 - $114,977	831 Added 0.45%	183,794 $21.7 Million
Q3 2021 Nov 04, 2021	BUY	$132.37 - $176.78 $1.74 Million - $2.32 Million	13,116 Added 7.72%	182,963 $24.5 Million
Q2 2021 Aug 11, 2021	BUY	$60.88 - $161.91 $2.35 Million - $6.25 Million	38,630 Added 29.44%	169,847 $27.5 Million
Q1 2021 May 13, 2021	BUY	$46.59 - $83.68 $955,095 - $1.72 Million	20,500 Added 18.52%	131,217 $10.5 Million
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $1.43 Million - $4.81 Million	75,752 Added 216.65%	110,717 $6.02 Million
Q3 2020 Nov 12, 2020	SELL	$17.47 - $24.93 $889,030 - $1.27 Million	-50,889 Reduced 59.27%	34,965 $694,000
Q2 2020 Aug 13, 2020	BUY	$11.14 - $22.87 $138,804 - $284,960	12,460 Added 16.98%	85,854 $1.81 Million
Q1 2020 May 14, 2020	SELL	$9.44 - $15.58 $452,553 - $746,905	-47,940 Reduced 39.51%	73,394 $897,000
Q4 2019 Feb 14, 2020	BUY	$10.43 - $17.67 $98,010 - $166,044	9,397 Added 8.39%	121,334 $1.78 Million
Q3 2019 Nov 14, 2019	SELL	$13.07 - $18.51 $1.47 Million - $2.08 Million	-112,291 Reduced 50.08%	111,937 $1.49 Million
Q2 2019 Aug 14, 2019	BUY	$13.88 - $18.41 $2.33 Million - $3.09 Million	167,707 Added 296.72%	224,228 $3.67 Million
Q1 2019 May 15, 2019	SELL	$12.79 - $17.62 $7.41 Million - $10.2 Million	-579,435 Reduced 91.11%	56,521 $963,000
Q4 2018 Feb 14, 2019	BUY	$11.39 - $27.13 $1.96 Million - $4.67 Million	172,309 Added 37.16%	635,956 $8.68 Million
Q3 2018 Dec 21, 2021	BUY	$25.78 - $32.6 $2.61 Million - $3.3 Million	101,192 Added 27.92%	463,647 $13.3 Million
Q3 2018 Nov 14, 2018	BUY	$25.78 - $32.6 $1.06 Million - $1.35 Million	41,288 Added 12.86%	362,455 $10.4 Million
Q2 2018 Apr 21, 2020	BUY	$20.02 - $30.79 $336,275 - $517,179	16,797 Added 5.52%	321,167 $8.79 Million
Q2 2018 Aug 14, 2018	SELL	$20.02 - $30.79 $960,839 - $1.48 Million	-47,994 Reduced 13.62%	304,370 $8.33 Million
Q1 2018 Oct 18, 2019	BUY	$19.43 - $34.95 $1.49 Million - $2.69 Million	76,915 Added 27.92%	352,364 $7.43 Million
Q1 2018 May 15, 2018	BUY	$19.43 - $34.95 $4.54 Million - $8.17 Million	233,705 Added 559.85%	275,449 $5.81 Million
Q4 2017 Feb 14, 2018	BUY	$17.39 - $31.12 $57,021 - $102,042	3,279 Added 8.52%	41,744 $800,000
Q3 2017 Nov 14, 2017	BUY	$15.16 - $25.75 $583,129 - $990,473	38,465	38,465 $954,000

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $997M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account